Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
Mateusz Legut, Dominik Lipka, Nina Filipczak, Adriana Piwoni, Arkadiusz Kozubek, Jerzy GubernatorDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wrocław, Wrocław, PolandAbstract: This paper describes a novel formulation of antineoplastic drug: mitoxantrone loaded into li...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd7d52ed25924c09b6b003ec4d50c6fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fd7d52ed25924c09b6b003ec4d50c6fd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fd7d52ed25924c09b6b003ec4d50c6fd2021-12-02T05:17:41ZAnacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies1178-2013https://doaj.org/article/fd7d52ed25924c09b6b003ec4d50c6fd2014-01-01T00:00:00Zhttp://www.dovepress.com/anacardic-acid-enhances-the-anticancer-activity-of-liposomal-mitoxantr-a15613https://doaj.org/toc/1178-2013 Mateusz Legut, Dominik Lipka, Nina Filipczak, Adriana Piwoni, Arkadiusz Kozubek, Jerzy GubernatorDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wrocław, Wrocław, PolandAbstract: This paper describes a novel formulation of antineoplastic drug: mitoxantrone loaded into liposomal carriers enriched with encapsulated anacardic acid in the liposomal bilayer using a vitamin C gradient. Anacardic acid is a potent epigenetic agent with anticancer activity. This is the first liposomal formulation to combine an actively encapsulated drug and anacardic acid. The liposomes were characterized in terms of basic parameters, such as size, zeta potential, optimal drug-to-lipid ratio, loading time and temperature, and stability at 4°C and in human plasma in vitro. The formulation was found to be stable, and the loading process was rapid and efficient (drug-to-lipid ratio of up to 0.3 with over 90% efficiency in 5 minutes). The cytotoxicity of these formulations was assessed using the human melanoma cell lines A375 and Hs294T and the normal human dermal fibroblast line. The results showed that anacardic acid and to a smaller extent vitamin C significantly increased the cytotoxicity of the drug towards melanoma compared to ammonium sulfate liposomes. On the other hand, vitamin C and anacardic acid both protected normal cells from damage caused by the drug. The formulation combining anacardic acid, vitamin C, and mitoxantrone showed promising results in terms of cytotoxicity and cytoprotection. Therefore, it has potential for anticancer treatment.Keywords: anacardic acid, vitamin C, ascorbic acid, liposomes, mitoxantrone, melanomaLegut MLipka DFilipczak NPiwoni AKozubek AGubernator JDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 653-668 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Legut M Lipka D Filipczak N Piwoni A Kozubek A Gubernator J Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies |
description |
Mateusz Legut, Dominik Lipka, Nina Filipczak, Adriana Piwoni, Arkadiusz Kozubek, Jerzy GubernatorDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wrocław, Wrocław, PolandAbstract: This paper describes a novel formulation of antineoplastic drug: mitoxantrone loaded into liposomal carriers enriched with encapsulated anacardic acid in the liposomal bilayer using a vitamin C gradient. Anacardic acid is a potent epigenetic agent with anticancer activity. This is the first liposomal formulation to combine an actively encapsulated drug and anacardic acid. The liposomes were characterized in terms of basic parameters, such as size, zeta potential, optimal drug-to-lipid ratio, loading time and temperature, and stability at 4°C and in human plasma in vitro. The formulation was found to be stable, and the loading process was rapid and efficient (drug-to-lipid ratio of up to 0.3 with over 90% efficiency in 5 minutes). The cytotoxicity of these formulations was assessed using the human melanoma cell lines A375 and Hs294T and the normal human dermal fibroblast line. The results showed that anacardic acid and to a smaller extent vitamin C significantly increased the cytotoxicity of the drug towards melanoma compared to ammonium sulfate liposomes. On the other hand, vitamin C and anacardic acid both protected normal cells from damage caused by the drug. The formulation combining anacardic acid, vitamin C, and mitoxantrone showed promising results in terms of cytotoxicity and cytoprotection. Therefore, it has potential for anticancer treatment.Keywords: anacardic acid, vitamin C, ascorbic acid, liposomes, mitoxantrone, melanoma |
format |
article |
author |
Legut M Lipka D Filipczak N Piwoni A Kozubek A Gubernator J |
author_facet |
Legut M Lipka D Filipczak N Piwoni A Kozubek A Gubernator J |
author_sort |
Legut M |
title |
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies |
title_short |
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies |
title_full |
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies |
title_fullStr |
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies |
title_full_unstemmed |
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies |
title_sort |
anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies |
publisher |
Dove Medical Press |
publishDate |
2014 |
url |
https://doaj.org/article/fd7d52ed25924c09b6b003ec4d50c6fd |
work_keys_str_mv |
AT legutm anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies AT lipkad anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies AT filipczakn anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies AT piwonia anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies AT kozubeka anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies AT gubernatorj anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies |
_version_ |
1718400510502895616 |